PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -99.9% | 470 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $12,058,000 | -49.7% | 522,000 | -35.1% | 0.25% | -45.9% |
| Q3 2021 | $23,959,000 | -12.8% | 804,000 | 0.0% | 0.47% | -4.1% |
| Q2 2021 | $27,465,000 | +97.1% | 804,000 | +89.8% | 0.49% | +66.6% |
| Q1 2021 | $13,935,000 | +21.0% | 423,680 | +126.3% | 0.29% | +28.5% |
| Q4 2020 | $11,514,000 | +548.7% | 187,192 | +274.4% | 0.23% | +430.2% |
| Q3 2020 | $1,775,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |